CHEMSPEC ORD A (SHH) EQSW Exp: (688602) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of CHEMSPEC ORD A (SHH) EQSW Exp: ¥5.18, price ¥6.90, upside -24.9%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch CHEMSPEC ORD A (SHH) EQSW Exp: for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
38‑month range ¥5.69 – ¥15.65 · fair‑value band ¥5.00 – ¥5.47 · the ¥6.90 price screens above the ¥5.18 fair value. Dashed = 300-day average. As of Sep 24, 2026.
Follow CHEMSPEC ORD A (SHH) EQSW Exp: in your weekly email
Every Wednesday you see whether CHEMSPEC ORD A (SHH) EQSW Exp: is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Shanghai Chemspec Corporation engages in the research, development, production, and sale of fine chemicals. It offers display material, new energy battery material, silicon and organosilicon materials, electronic chemical, functional materials, other special chemicals. The company also provides pharmaceutical and pesticide chemicals.
Show more
Shanghai Chemspec Corporation engages in the research, development, production, and sale of fine chemicals. It offers display material, new energy battery material, silicon and organosilicon materials, electronic chemical, functional materials, other special chemicals. The company also provides pharmaceutical and pesticide chemicals. The company was founded in 1996 and is headquartered in Shanghai, China.
Stock analysis
CHEMSPEC ORD A (SHH) EQSW Exp: (688602) currently trades at ¥6.90, while our model-based Fair Value estimate is ¥5.18, implying the stock looks roughly 33.2% overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of ¥3.50 per share, and 0 of the 12 models we run sit above the ¥6.90 price.
Bear case: the Multiples group reads lowest at ¥2.46, and 12 of the 12 models stay below the price. Evidence for this calculation is low.
Scenario range: ¥5.00 (bear) to ¥5.47 (bull), the price of ¥6.90 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
CHEMSPEC ORD A (SHH) EQSW Exp: reported revenue of 770M CNY in FY2025 versus 1.0B CNY in FY2021, a compound −6.4%/yr. Reported net income was −64.2M CNY in FY2025.
Key figures
Market cap 3.6B CNY (≈ $535M) · P/S ratio 5.15 · EPS (TTM) ¥−0.2000 · Dividend yield 0.1% · Net margin −8.3% · Return on equity −3.9% · Return on assets (EBIT) 2.9% · Operating margin −13.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).
What moves the price
The share trades about 41% below its 52-week high and 16% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −25% fair-value upside, at −25%, 688602 screens cheaper than that median.
Fair Value models
Bear ¥5.00Fair Value ¥5.18Bull ¥5.47
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.24/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+14.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−14.7%
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
18.9% (2021) → −4.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+59.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +56.6% a year for the price.
Compare CHEMSPEC ORD A (SHH) EQSW Exp: with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 350 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score42 · Below median
Fair Value upside−25% · Above median
Profitability
Return on assets−3% · Bottom 25%
Net margin (TTM)−16% · Bottom 25%
Operating margin (TTM)−13% · Bottom 25%
Growth and dividend
Revenue growth−38% · Bottom 25%
Dividend yield (TTM)0.1% · Bottom 25%
Balance sheet
Debt / equity0.03× · Below median
Valuation Multiplesvs Chemicals median · lower = cheaper
P/B0.20× · Cheapest 25%
P/S (TTM)0.79× · Cheaper than median
P/FCF43.6× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 24
PAST (return on equity)0· sector 19
HEALTH (low debt)99· sector 94
DIVIDEND (yield)3· sector 31
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "CHEMSPEC ORD A (SHH) EQSW Exp: Fair Value". https://www.fairvalue-calculator.com/stock/688602
Frequently asked questions
Is CHEMSPEC ORD A (SHH) EQSW Exp: (688602) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ¥5.18 versus a price of ¥6.90, about −25% upside (overvalued).
What is the fair value of 688602?
Our model-based fair value for CHEMSPEC ORD A (SHH) EQSW Exp: is ¥5.18 (as of Sep 24, 2026), built from audited fundamentals. The current price: ¥6.90.
What is the quality score of 688602?
CHEMSPEC ORD A (SHH) EQSW Exp: has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
Our model-based price target is the fair value of ¥5.18 (as of Sep 24, 2026) from 12 valuation models. Cautious scenario ¥5.00, optimistic scenario ¥5.47. It is a calculation from audited fundamentals, not an analyst target.
What is the CHEMSPEC ORD A (SHH) EQSW Exp: stock forecast for 2026?
Our models put fair value at ¥5.18, about −25% upside versus a price of ¥6.90 (overvalued). Cautious scenario ¥5.00, optimistic scenario ¥5.47. The calculation is refreshed regularly with new filings.
What is the revenue of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
CHEMSPEC ORD A (SHH) EQSW Exp: reported trailing-twelve-month revenue of about 676M CNY (latest available figure, as of Sep 24, 2026).
Does CHEMSPEC ORD A (SHH) EQSW Exp: pay a dividend?
CHEMSPEC ORD A (SHH) EQSW Exp: currently shows a dividend yield of about 0.14% relative to its recent price (as of Sep 24, 2026).
What growth is priced into CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
For today's price to be fair in a discounted-cash-flow model, CHEMSPEC ORD A (SHH) EQSW Exp: would have to grow free cash flow by +59.2 % per year for five years (discount rate 10.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 4 years revenue grew -6.5 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 688602 use?
Our models discount CHEMSPEC ORD A (SHH) EQSW Exp: at 10.4 %: a base by market capitalisation (small), damped by beta 0.17, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For CHEMSPEC ORD A (SHH) EQSW Exp: that is +59.2 % per year a year over ten years, using the same discount rate (10.4 %) and the same formula as our fair value.
How much growth has CHEMSPEC ORD A (SHH) EQSW Exp: (688602) delivered so far?
Over the past 4 years revenue at CHEMSPEC ORD A (SHH) EQSW Exp: grew -6.5 % a year. The price currently implies +59.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of CHEMSPEC ORD A (SHH) EQSW Exp: (688602) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into CHEMSPEC ORD A (SHH) EQSW Exp: (+59.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
The free-cash-flow yield on the price is 0.34 %: that much free cash flow CHEMSPEC ORD A (SHH) EQSW Exp: produces per unit of market value. When it exceeds the discount rate of our models (10.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CHEMSPEC ORD A (SHH) EQSW Exp: it is ¥5.18 per share (as of Sep 24, 2026), against a price of ¥6.90. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is CHEMSPEC ORD A (SHH) EQSW Exp: stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 688602 trades above its calculated fair value: price ¥6.90, fair value ¥5.18, a gap of about −25% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 688602?
No. The price is what the market pays today (¥6.90); the fair value is what the company's own numbers justify (¥5.18). For CHEMSPEC ORD A (SHH) EQSW Exp: the two are ¥1.72 per share apart. That gap is exactly why we show both numbers side by side.
How much is CHEMSPEC ORD A (SHH) EQSW Exp: worth?
The market values CHEMSPEC ORD A (SHH) EQSW Exp: at about 3.6B CNY (market capitalisation, as of Sep 24, 2026). Per share that is ¥6.90; our models calculate a fair value of ¥5.18 per share.
What do the bullish and bearish scenarios say about 688602?
Our models span a range for CHEMSPEC ORD A (SHH) EQSW Exp:: cautious scenario ¥5.00, base ¥5.18, optimistic ¥5.47 per share (as of Sep 24, 2026, price ¥6.90). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
Balance-sheet figures for CHEMSPEC ORD A (SHH) EQSW Exp: (as of Sep 24, 2026): return on equity −3.9%, debt of 0.03 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is 688602 from its 52-week high?
CHEMSPEC ORD A (SHH) EQSW Exp: trades at ¥6.90, about 41% below its 52-week high of ¥11.60 and 16% above the low of ¥5.95 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of ¥5.18 is for.
Which stocks are comparable to CHEMSPEC ORD A (SHH) EQSW Exp:?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Ningxia Baofeng Energy Group, Dow Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CHEMSPEC ORD A (SHH) EQSW Exp: stock attractive at the current price?
The data as of Sep 24, 2026: price ¥6.90, calculated fair value ¥5.18 (−25%), Quality Score 42/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 688602 calculated?
We run CHEMSPEC ORD A (SHH) EQSW Exp: through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥5.18, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. CHEMSPEC ORD A (SHH) EQSW Exp: itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
The closing price on Sep 23, 2026 was ¥6.90. Our model-based fair value is ¥5.18, about −25% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CHEMSPEC ORD A (SHH) EQSW Exp: right now?
The price sits above even our optimistic bull case (¥5.47). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. The models converge in a tight band (¥5.00 to ¥5.47), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of CHEMSPEC ORD A (SHH) EQSW Exp:
How large is the market capitalisation of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
The market capitalisation of CHEMSPEC ORD A (SHH) EQSW Exp: is 3.6B CNY (≈ $535M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
The price-to-sales ratio of CHEMSPEC ORD A (SHH) EQSW Exp: is 5.15 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
Earnings per share at CHEMSPEC ORD A (SHH) EQSW Exp: are ¥−0.2000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
The dividend yield of CHEMSPEC ORD A (SHH) EQSW Exp: is 0.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
The net margin of CHEMSPEC ORD A (SHH) EQSW Exp: is −8.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
The return on equity (ROE) of CHEMSPEC ORD A (SHH) EQSW Exp: is −3.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
On an EBIT basis the return on assets of CHEMSPEC ORD A (SHH) EQSW Exp: is 2.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
The operating margin of CHEMSPEC ORD A (SHH) EQSW Exp: is −13.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CHEMSPEC ORD A (SHH) EQSW Exp: (688602)?
Revenue at CHEMSPEC ORD A (SHH) EQSW Exp: is growing −38.4% versus a year earlier (3y avg −14.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
Free · no account needed
Watch CHEMSPEC ORD A (SHH) EQSW Exp: in the live analysis
One click puts CHEMSPEC ORD A (SHH) EQSW Exp: on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
